キャリアスクリーニングの世界市場レポート 2025年

キャリアスクリーニングの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は16.2%で57億6,000万米ドルに成長します。予測期間の成長は、精密医療の進歩、パネル提供の拡大、消費者ゲノミクスと消費者直接検査、希少・超希少疾患への注力、政府と保険による支援、薬理ゲノミクスの統合などに起因すると考えられます。予測期間における主な動向には、遺伝子技術の進歩、出生前検査との統合、個別化医療の台頭、カウンセリングと教育サービス、倫理的・法的考察などが含まれます。

胎児の染色体異常と遺伝性疾患の増加が予想され、キャリアスクリーニング市場の成長を牽引します。胎児染色体異常は、染色体内のDNAの数や量に異常があり、胎児に影響を与えます。染色体異常の出生前検査は、そのような障害を持つ胎児のリスクを評価する上で重要な役割を果たしています。2022年2月の世界保健機関（WHO）の推計によると、先天性異常は、年間24万人の新生児が生後28日以内に死亡し、さらに生後1カ月から5歳までの子どもの間で17万人が死亡しています。さらに、国連政府による2022年3月の記事では、ダウン症は世界全体で1,000～1,100人に1人の割合で発症し、年間3,000～5,000人が出生していることが示されています。このような胎児の染色体異常や遺伝性疾患の急増は、キャリアスクリーニング市場の成長を促す重要な要因です。

高齢者人口の増加は、キャリアスクリーニング市場の今後の成長を促進すると予測されています。高齢者人口とは、高齢者またはそれ以上の年齢の個人を指します。高齢者、特に晩婚や後年に親になることを考えている人々は、遺伝的リスクを評価するために、妊娠前または受胎前ケアの一環としてキャリアスクリーニングを選択することがあります。例えば、2024年10月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上になると指摘しました。2050年には、60歳以上の世界人口は倍増し、21億人に達すると予想されています。さらに、80歳以上の人口は2020年から2050年にかけて3倍に増え、4億2,600万人に達すると予想されています。人口の高齢化率は以前と比べて加速しています。したがって、高齢者人口の増加がキャリアスクリーニング市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のキャリアスクリーニング市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のキャリアスクリーニング市場：成長率分析
• 世界のキャリアスクリーニング市場の実績：規模と成長、2019～2024年
• 世界のキャリアスクリーニング市場の予測：規模と成長、2024～2029年、2034年
• 世界のキャリアスクリーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のキャリアスクリーニング市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 拡張キャリアスクリーニング
• 対象疾患キャリアスクリーニング
• 世界のキャリアスクリーニング市場：病状別、実績と予測、2019～2024年、2024～2029年、2034年
• 肺疾患
• 血液疾患
• 神経疾患
• その他
• 世界のキャリアスクリーニング市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• DNA配列解析
• ポリメラーゼ連鎖反応
• マイクロアレイ
• その他
• 世界のキャリアスクリーニング市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• リファレンスラボ
• 医院・クリニック
• その他
• 世界のキャリアスクリーニング市場：拡張キャリアスクリーニングのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 全エクソームシーケンス（WES）
• 次世代シーケンシング（NGS）パネル
• 包括的キャリアスクリーニングテスト
• 世界のキャリアスクリーニング市場：対象疾患キャリアスクリーニングのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単一遺伝子検査
• 疾患特異的パネル
• 民族または集団特異的スクリーニング検査

第7章 地域別・国別分析

• 世界のキャリアスクリーニング市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のキャリアスクリーニング市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• キャリアスクリーニング市場：競合情勢
• キャリアスクリーニング市場：企業プロファイル
  • Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Centogene NV Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Fulgent Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Genealogy by Genetics Ltd.
• Illumina Inc.
• Laboratory Corporation of America Holdings
• Luminex Corporation
• MedGenome Inc.
• Myriad Genetics Inc.
• Natera Inc.
• OPKO Health Inc.
• Otogenetics Corporation
• Quest Diagnostics Inc.
• Sema4 Holdings Corporation
• Thermo Fisher Scientific Inc.
• 23andMe Holding Co.
• REALM IDx Inc.
• Associated Regional and University Pathologists Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• キャリアスクリーニング市場2029年：新たな機会を提供する国
• キャリアスクリーニング市場2029年：新たな機会を提供するセグメント
• キャリアスクリーニング市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Carrier screening is a genetic testing method designed to identify the presence of genes associated with specific genetic illnesses. This screening helps determine if individuals carry a gene mutation that, when present in two copies, can lead to hereditary diseases.

Two primary types of carrier screening are utilized such as expanded carrier screening and targeted disease carrier screening. Expanded carrier screening offers assessment for multiple autosomal and X-linked recessive disorders, leveraging advanced genetic testing technologies. This approach allows testing for individuals regardless of their ancestry or geographic origin. The products and services associated with carrier screening fall into the categories of service and product. The medical conditions covered include pulmonary conditions, hematological conditions, neurological conditions, and other relevant medical conditions. The technologies involved in carrier screening encompass DNA sequencing, polymerase chain reaction, microarrays, and various other technologies. Carrier screening services are utilized by a range of end users, including hospitals, reference laboratories, physician offices and clinics, and other entities involved in healthcare and genetic testing.

The carrier screening market research report is one of a series of new reports from The Business Research Company that provides carrier screening market statistics, including carrier screening industry global market size, regional shares, competitors with a carrier screening market share, detailed carrier screening market segments, market trends and opportunities, and any further data you may need to thrive in the carrier screening industry. This carrier screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The carrier screening market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increasing genetic disorders awareness, rising maternal age, family planning and pregnancy awareness, prevention of genetic diseases, public health initiatives, increased focus on inherited conditions.

The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to precision medicine advancements, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on rare and ultra-rare diseases, government and insurance support, pharmacogenomics integration. Major trends in the forecast period include advancements in genetic technologies, integration with prenatal testing, rise in personalized medicine, counseling and education services, ethical and legal considerations.

The anticipated increase in fetal chromosomal abnormalities and genetic disorders is set to drive the growth of the carrier screening market. Fetal chromosomal abnormalities involve deviations in the number or quantity of DNA within a chromosome, impacting a fetus. Prenatal testing for chromosomal abnormalities plays a crucial role in assessing the risk of carrying a fetus with such disorders. According to estimates from the World Health Organization in February 2022, birth defects contribute to the demise of 240,000 newborns in the first 28 days annually, with an additional 170,000 deaths among children aged 1 month to 5 years. Additionally, an article by the United Nations Government in March 2022 highlights that Down syndrome affects 1 in 1,000 to 1 in 1,100 live births globally, resulting in 3,000 to 5,000 annual births. This surge in fetal chromosomal abnormalities and genetic disorders is a significant driver for the growth of the carrier screening market.

The growing geriatric population is projected to enhance the growth of the carrier screening market in the future. The geriatric population refers to individuals who are elderly or older in age. Older adults, particularly those considering parenthood later in life, may choose carrier screening as part of their prenatal or preconception care to assess the genetic risks linked to advanced parental age. For instance, in October 2024, the World Health Organization, a Switzerland-based intergovernmental organization, indicated that by 2030, 1 in 6 people globally will be aged 60 years or older. By 2050, the global population of individuals aged 60 and above is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 and older is anticipated to triple from 2020 to 2050, reaching 426 million. The rate of population aging is accelerating compared to previous years. Therefore, the rising geriatric population is propelling growth in the carrier screening market.

Major companies in the carrier screening market are concentrating on product developments, such as screening tests family, to maintain their market positions. Screening tests, aimed at asymptomatic individuals, are crucial in identifying risks associated with various conditions, including those related to pregnancy, family planning, and overall health. For example, Blueprint Genetics, a Finland-based genetic testing and diagnostics company, introduced the Screening Tests family in June 2023. This offering aims to provide actionable information for proactive decision-making related to family planning and health, supporting individuals in making informed choices about their well-being.

In the carrier screening market, major companies are also focusing on product developments, such as carrier screening panels, to sustain their market positions. Carrier screening panels involve genetic tests to identify individuals carrying gene mutations for specific conditions, even without exhibiting symptoms. In February 2023, Fulgent Genetics, Inc., a US-based genetic testing and diagnostics company, launched the Beacon787 expanded carrier screening panel. This comprehensive panel covers 787 genes associated with autosomal recessive and X-linked conditions, aligning with guidelines advocating for comprehensive screening for all pregnant and planning individuals. Fulgent's Beacon787 aims to provide equitable and pan-ethnic screening, emphasizing its commitment to advancing genetic testing and promoting informed family planning decisions.

In a strategic move, Sema4 OpCo Inc., a US-based provider of patient-focused health intelligence, acquired GeneDx LLC for $623 million in May 2022. This acquisition positions Sema4 as a prominent genomic testing company in the United States, enhancing its health information database and contributing to improved patient care and therapeutic research. GeneDx LLC, a US-based company specializing in the analysis of rare disorders and genomic testing, becomes an integral part of Sema4's commitment to advancing genomic insights in healthcare.

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the carrier screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The carrier screening market includes revenues earned by entities by providing customized panel testing and predesigned panel testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Carrier Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on carrier screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for carrier screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The carrier screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening
• 2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions
• 3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies
• 4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users
• Subsegments:
• 1) By Expanded Carrier Screening: Whole Exome Sequencing (WES); Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests
• 2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests
• Companies Mentioned: Invitae Corporation; BGI Genomics Co. Ltd.; Centogene NV; Eurofins Scientific SE; Fulgent Genetics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Carrier Screening Market Characteristics

3. Carrier Screening Market Trends And Strategies

4. Carrier Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Carrier Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Carrier Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Carrier Screening Market Growth Rate Analysis
• 5.4. Global Carrier Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Carrier Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Carrier Screening Total Addressable Market (TAM)

6. Carrier Screening Market Segmentation

• 6.1. Global Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expanded Carrier Screening
• Targeted Disease Carrier Screening
• 6.2. Global Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Conditions
• Hematological Conditions
• Neurological Conditions
• Other Medical Conditions
• 6.3. Global Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Other Technologies
• 6.4. Global Carrier Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Reference Laboratories
• Physician Offices And Clinics
• Other End Users
• 6.5. Global Carrier Screening Market, Sub-Segmentation Of Expanded Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Exome Sequencing (WES)
• Next-Generation Sequencing (NGS) Panels
• Comprehensive Carrier Screening Tests
• 6.6. Global Carrier Screening Market, Sub-Segmentation Of Targeted Disease Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Gene Tests
• Disease-Specific Panels
• Ethnic Or Population-Specific Screening Tests

7. Carrier Screening Market Regional And Country Analysis

• 7.1. Global Carrier Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Carrier Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Carrier Screening Market

• 8.1. Asia-Pacific Carrier Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Carrier Screening Market

• 9.1. China Carrier Screening Market Overview
• 9.2. China Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Carrier Screening Market

• 10.1. India Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Carrier Screening Market

• 11.1. Japan Carrier Screening Market Overview
• 11.2. Japan Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Carrier Screening Market

• 12.1. Australia Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Carrier Screening Market

• 13.1. Indonesia Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Carrier Screening Market

• 14.1. South Korea Carrier Screening Market Overview
• 14.2. South Korea Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Carrier Screening Market

• 15.1. Western Europe Carrier Screening Market Overview
• 15.2. Western Europe Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Carrier Screening Market

• 16.1. UK Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Carrier Screening Market

• 17.1. Germany Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Carrier Screening Market

• 18.1. France Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Carrier Screening Market

• 19.1. Italy Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Carrier Screening Market

• 20.1. Spain Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Carrier Screening Market

• 21.1. Eastern Europe Carrier Screening Market Overview
• 21.2. Eastern Europe Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Carrier Screening Market

• 22.1. Russia Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Carrier Screening Market

• 23.1. North America Carrier Screening Market Overview
• 23.2. North America Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Carrier Screening Market

• 24.1. USA Carrier Screening Market Overview
• 24.2. USA Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Carrier Screening Market

• 25.1. Canada Carrier Screening Market Overview
• 25.2. Canada Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Carrier Screening Market

• 26.1. South America Carrier Screening Market Overview
• 26.2. South America Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Carrier Screening Market

• 27.1. Brazil Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Carrier Screening Market

• 28.1. Middle East Carrier Screening Market Overview
• 28.2. Middle East Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Carrier Screening Market

• 29.1. Africa Carrier Screening Market Overview
• 29.2. Africa Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Carrier Screening Market Competitive Landscape And Company Profiles

• 30.1. Carrier Screening Market Competitive Landscape
• 30.2. Carrier Screening Market Company Profiles
  • 30.2.1. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Centogene NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fulgent Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Carrier Screening Market Other Major And Innovative Companies

• 31.1. Genealogy by Genetics Ltd.
• 31.2. Illumina Inc.
• 31.3. Laboratory Corporation of America Holdings
• 31.4. Luminex Corporation
• 31.5. MedGenome Inc.
• 31.6. Myriad Genetics Inc.
• 31.7. Natera Inc.
• 31.8. OPKO Health Inc.
• 31.9. Otogenetics Corporation
• 31.10. Quest Diagnostics Inc.
• 31.11. Sema4 Holdings Corporation
• 31.12. Thermo Fisher Scientific Inc.
• 31.13. 23andMe Holding Co.
• 31.14. REALM IDx Inc.
• 31.15. Associated Regional and University Pathologists Inc.

32. Global Carrier Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Carrier Screening Market

34. Recent Developments In The Carrier Screening Market

35. Carrier Screening Market High Potential Countries, Segments and Strategies

• 35.1 Carrier Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Carrier Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Carrier Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer